Why Unilever Paid $1.2 Bn for a 3-Year-Old Gummy Brand

Consumer goods giant Unilever has signed an agreement to acquire Grüns, the fast-growing US-based greens supplement company, for $1.2 Bn (approximately Rs 9,960 Cr) — a deal that values the three-year-old brand at more than double its last known private valuation of $500 Mn, set during a Series B funding round in 2025.

The acquisition signals Unilever’s most decisive pivot yet toward premium wellness: a deliberate shift away from traditional food toward beauty, wellbeing, and personal care, targeting two-thirds of group revenue from these categories. With Grüns shipping 10 million gummies daily to over one million customers — a scale competitors and retailers will be watching closely — Unilever gains not just a brand but a proven adherence model that has cracked the supplement industry’s most persistent problem.

Deal Structure

The deal is Unilever’s first acquisition since announcing last month its plan to combine food operations with spice giant McCormick — a structural signal that the FMCG conglomerate is aggressively rebalancing its portfolio toward wellness and personal care.

Strategic Rationale — Why Grüns, Why Now

Grüns solved a problem that has plagued the supplement industry for decades: adherence. Most consumers who buy vitamins abandon them within weeks. Grüns reframed supplementation as an enjoyable daily ritual — a gummy bear format packing over 60 ingredients including 30+ organic fruits and vegetables, 21 vitamins and minerals, and 6 grams of prebiotic fiber.

The result: 95% of customers use the product four to six times per week, a retention metric that rivals category benchmarks and gives Unilever a powerful retention engine to layer atop its existing distribution infrastructure.

Grüns — Target Company Snapshot

Valuation Analysis

The 4x revenue multiple reflects Grüns’ exceptional retention metrics and DTC brand equity. At $1.2 Bn, Unilever is pricing in the brand’s distribution upside — not just its current scale — projecting the brand to reach $500 Mn+ in revenue under FMCG-level retail reach within three years.

Competitive Impact — Who Should Be Watching?

Unilever’s Wellness Acquisition Trail

What’s Next

Unilever’s primary integration challenge will be scale without dilution: the brand’s identity is built on a digitally native, culture-driven community that resists mass-market genericisation. Unilever’s track record with Liquid IV and Nutrafol suggests the company has learned to allow acquired wellness brands to retain their voice while adding distribution muscle.

Within 18 months of closing, expect Grüns to launch in European and Asia-Pacific markets — potentially with India and Southeast Asia as priority targets, given growing middle-class appetite for premium nutrition. The cognitive (Nütrops) and immune (Immün) product lines are most positioned for international scaling.

The deeper question: does Grüns’ success accelerate a bidding war for other adherence-first wellness brands — specifically in the functional gummy format? If yes, the $1.2 Bn deal will be remembered not just as an acquisition but as the moment FMCG majors recognised that habit design is the new moat in consumer health.